FDA NDC Directory · JSON-LD · Markdown

Lacosamide

NDC 65219-204 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214677
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsLACOSAMIDE (10 mg/mL)
Marketing started20220725
Package count1

External sources

Source: openFDA. Public-domain (CC0).